Avantor, Inc. Capital Expenditures
Avantor, Inc. (AVTR) reported Capital Expenditures of $33.50 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-04-29
- Avantor, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $33.50M, a 19.64% increase year-over-year.
- Avantor, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $35.50M, a 29.09% increase year-over-year.
- Avantor, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $35.70M, a 12.50% decline year-over-year.
- Avantor, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $29.60M, a 35.37% decline year-over-year.
- Avantor, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $128.80M, a 13.44% decline from fiscal 2024.
- Avantor, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $148.80M, a 1.64% increase from fiscal 2023.
- Avantor, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $146.40M, a 9.75% increase from fiscal 2022.
- Avantor, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $133.40M, a 20.07% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-03-31 | $33.50M 10-Q · filed 2026-04-29 | $69.00M derived: sum of 2 quarters · filed 2026-04-29 | $104.70M derived: sum of 3 quarters · filed 2026-04-29 | $134.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $35.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $71.20M derived: sum of 2 quarters · filed 2026-02-11 | $100.80M derived: sum of 3 quarters · filed 2026-02-11 | $128.80M 10-K · filed 2026-02-11 |
| 2025-09-30 | $35.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $65.30M derived: sum of 2 quarters · filed 2025-10-29 | $93.30M 10-Q · filed 2025-10-29 | $120.80M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $29.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $57.60M 10-Q · filed 2025-08-01 | $85.10M derived: sum of 3 quarters · filed 2026-04-29 | $125.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $28.00M 10-Q · filed 2026-04-29 | $55.50M derived: sum of 2 quarters · filed 2026-04-29 | $96.30M derived: sum of 3 quarters · filed 2026-04-29 | $142.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $27.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $68.30M derived: sum of 2 quarters · filed 2026-02-11 | $114.10M derived: sum of 3 quarters · filed 2026-02-11 | $148.80M 10-K · filed 2026-02-11 |
| 2024-09-30 | $40.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $86.60M derived: sum of 2 quarters · filed 2025-10-29 | $121.30M 10-Q · filed 2025-10-29 | $171.90M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | $45.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $80.50M 10-Q · filed 2025-08-01 | $131.10M derived: sum of 3 quarters · filed 2026-02-11 | $168.80M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | $34.70M 10-Q · filed 2025-04-25 | $85.30M derived: sum of 2 quarters · filed 2026-02-11 | $123.00M derived: sum of 3 quarters · filed 2026-02-11 | $153.10M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $50.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $88.30M derived: sum of 2 quarters · filed 2026-02-11 | $118.40M derived: sum of 3 quarters · filed 2026-02-11 | $146.40M 10-K · filed 2026-02-11 |
| 2023-09-30 | $37.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | $67.80M derived: sum of 2 quarters · filed 2024-10-25 | $95.80M 10-Q · filed 2024-10-25 | $129.40M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $30.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | $58.10M 10-Q · filed 2024-07-26 | $91.70M derived: sum of 3 quarters · filed 2025-02-07 | $130.70M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $28.00M 10-Q · filed 2024-04-26 | $61.60M derived: sum of 2 quarters · filed 2025-02-07 | $100.60M derived: sum of 3 quarters · filed 2025-02-07 | $136.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $33.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $72.60M derived: sum of 2 quarters · filed 2025-02-07 | $108.90M derived: sum of 3 quarters · filed 2025-02-07 | $133.40M 10-K · filed 2025-02-07 |
| 2022-09-30 | $39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $75.30M derived: sum of 2 quarters · filed 2023-10-27 | $99.80M 10-Q · filed 2023-10-27 | $139.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $36.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $60.80M 10-Q · filed 2023-07-28 | $100.80M derived: sum of 3 quarters · filed 2024-02-14 | $133.40M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $24.50M 10-Q · filed 2023-04-28 | $64.50M derived: sum of 2 quarters · filed 2024-02-14 | $97.10M derived: sum of 3 quarters · filed 2024-02-14 | $120.50M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $40.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $72.60M derived: sum of 2 quarters · filed 2024-02-14 | $96.00M derived: sum of 3 quarters · filed 2024-02-14 | $111.10M 10-K · filed 2024-02-14 |
| 2021-09-30 | $32.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $56.00M derived: sum of 2 quarters · filed 2022-10-28 | $71.10M 10-Q · filed 2022-10-28 | $91.30M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $23.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $38.50M 10-Q · filed 2022-07-29 | $58.70M derived: sum of 3 quarters · filed 2023-02-14 | $74.00M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $15.10M 10-Q · filed 2022-04-29 | $35.30M derived: sum of 2 quarters · filed 2023-02-14 | $50.60M derived: sum of 3 quarters · filed 2023-02-14 | $64.10M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $20.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $35.50M derived: sum of 2 quarters · filed 2023-02-14 | $49.00M derived: sum of 3 quarters · filed 2023-02-14 | $61.60M 10-K · filed 2023-02-14 |
| 2020-09-30 | $15.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $28.80M derived: sum of 2 quarters · filed 2021-10-29 | $41.40M 10-Q · filed 2021-10-29 | $53.50M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $13.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $26.10M 10-Q · filed 2021-07-30 | $38.20M derived: sum of 3 quarters · filed 2022-02-11 | $51.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | $12.60M 10-Q · filed 2021-04-28 | $24.70M derived: sum of 2 quarters · filed 2022-02-11 | $37.80M derived: sum of 3 quarters · filed 2022-02-11 | $51.80M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $12.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | $25.20M derived: sum of 2 quarters · filed 2022-02-11 | $39.20M derived: sum of 3 quarters · filed 2022-02-11 | $51.60M 10-K · filed 2022-02-11 |
| 2019-09-30 | $13.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | $27.10M derived: sum of 2 quarters · filed 2020-10-27 | $39.50M 10-Q · filed 2020-10-27 | $44.90M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $14.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $26.40M 10-Q · filed 2020-07-29 | $31.80M derived: sum of 3 quarters · filed 2021-02-16 | $41.00M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | $12.40M 10-Q · filed 2020-04-29 | $17.80M derived: sum of 2 quarters · filed 2021-02-16 | $27.00M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2018-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $14.60M derived: sum of 2 quarters · filed 2021-02-16 | $37.70M 10-K · filed 2021-02-16 | |
| 2018-09-30 | $9.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $32.30M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | $23.10M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | $25.20M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |